# Akamai Technologies

Type: Company (AKAM)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/akamai-technologies
Canonical HTML page: https://getbiobrief.com/entity/akamai-technologies

## Recent coverage (1 stories)

### Invenomic Capital Exits $24M Haemonetics Stake Amid MedTech Underperformance
2026-03-21 01:09:37 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Invenomic Capital Management has fully liquidated its $24.29 million position in Haemonetics Corporation, signaling a shift away from the underperforming medical device maker. The exit comes as Haemonetics shares have lagged the broader market, dropping 9% over the past year while the fund rotates capital into diversified healthcare and technology plays.
Full story: https://getbiobrief.com/story/invenomic-capital-exits-haemonetics-stake-medtech-underperformance

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.